Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kura Oncology, Inc. | President and CEO, Director | Common Stock | 300K | $6.07M | $20.23 | Jan 24, 2024 | by Lorax Charitable Remainder Unitrust |
Kura Oncology, Inc. | President and CEO, Director | Common Stock | 279K | $5.65M | $20.23 | Jan 24, 2024 | by One Fish Two Fish Revocable Trust |
Avidity Biosciences, Inc. | Director | Common Stock | 300K | $3.04M | $10.13 | Dec 12, 2023 | By trust FBO Children 1 and 2 |
Avidity Biosciences, Inc. | Director | Common Stock | 300K | $3.04M | $10.13 | Dec 12, 2023 | By trust FBO Children 3 and 4 |
Avidity Biosciences, Inc. | Director | Common Stock | 62.7K | $635K | $10.13 | Dec 12, 2023 | Direct |
Avidity Biosciences, Inc. | Director | Common Stock | 35.6K | $360K | $10.13 | Dec 12, 2023 | By trust FBO Child 1 |
Avidity Biosciences, Inc. | Director | Common Stock | 35.6K | $360K | $10.13 | Dec 12, 2023 | By trust FBO Child 2 |
Avidity Biosciences, Inc. | Director | Common Stock | 13.7K | $139K | $10.13 | Dec 12, 2023 | By family trust |
Avidity Biosciences, Inc. | Director | Common Stock | 11.9K | $120K | $10.13 | Dec 12, 2023 | By trust FBO Child 3 |
Avidity Biosciences, Inc. | Director | Common Stock | 11.9K | $120K | $10.13 | Dec 12, 2023 | By trust FBO Child 4 |
PUMA BIOTECHNOLOGY, INC. | Director | Common Stock | 27.4K | $91.1K | $3.33 | Jun 18, 2024 | Direct |
Kura Oncology, Inc. | President and CEO, Director | Common Stock | 559 | $11.3K | $20.23 | Jan 24, 2024 | Direct |
PUMA BIOTECHNOLOGY, INC. | Director | Common Stock | 400 | $1.33K | $3.33 | Jun 18, 2024 | By Child #1 |
PUMA BIOTECHNOLOGY, INC. | Director | Common Stock | 150 | $499 | $3.33 | Jun 18, 2024 | By Child #2 |
Kura Oncology, Inc. | President and CEO, Director | Option to purchase common stock | 560K | Jan 2, 2024 | Direct | ||
Avidity Biosciences, Inc. | Director | Stock Option (Right to Buy) | 13.5K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PBYI | PUMA BIOTECHNOLOGY, INC. | Jun 18, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
PBYI | PUMA BIOTECHNOLOGY, INC. | Jun 13, 2024 | 1 | -$89.9K | 4 | Jun 17, 2024 | Director |
RNA | Avidity Biosciences, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
KURA | Kura Oncology, Inc. | Jan 24, 2024 | 4 | -$1.29M | 4 | Jan 26, 2024 | President and CEO, Director |
KURA | Kura Oncology, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | President and CEO, Director |
RNA | Avidity Biosciences, Inc. | Dec 12, 2023 | 4 | $0 | 4 | Dec 14, 2023 | Director |
KURA | Kura Oncology, Inc. | Dec 7, 2023 | 2 | $0 | 4 | Dec 11, 2023 | President and CEO, Director |
RNA | Avidity Biosciences, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
PBYI | PUMA BIOTECHNOLOGY, INC. | Jun 13, 2023 | 2 | -$93.3K | 4 | Jun 15, 2023 | Director |
KURA | Kura Oncology, Inc. | Jun 2, 2023 | 8 | $0 | 4 | Jun 2, 2023 | President and CEO, Director |
KURA | Kura Oncology, Inc. | Jul 14, 2022 | 8 | $0 | 4 | Feb 21, 2023 | President and CEO, Director |
PBYI | PUMA BIOTECHNOLOGY, INC. | Jun 16, 2022 | 1 | -$72K | 4 | Jun 21, 2022 | Director |
RNA | Avidity Biosciences, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
PBYI | PUMA BIOTECHNOLOGY, INC. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
KURA | Kura Oncology, Inc. | Jan 26, 2022 | 1 | $0 | 4 | Jan 28, 2022 | President and CEO, Director |
RNA | Avidity Biosciences, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |
PBYI | PUMA BIOTECHNOLOGY, INC. | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
PBYI | PUMA BIOTECHNOLOGY, INC. | Jun 10, 2021 | 1 | -$292K | 4 | Jun 11, 2021 | Director |